8-K ·Filed May 28, 2026

IRTC

iRhythm Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001388658-26-000049
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Routine annual meeting results with no surprises. The 2026 Equity Incentive Plan approval is standard and does not signal any change in business outlook. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
IRTC ▲ +11.17% at T+60d
NEUTRAL call ✓ call won +11.17% · α vs SPY +9.43% · entry $115.61 → $128.52
Entry anchored
May 28, 2026
via day open
T+1d
-1.48%
call -1.48% · α -1.72%
$113.90
settled 4mo ago
T+5d
-7.14%
call -7.14% · α -7.46%
$107.35
settled 4mo ago
T+20d
+2.84%
call +2.84% · α +5.98%
$118.89
settled 3mo ago
T+60d
+11.17%
call +11.17% · α +9.43%
$128.52
settled 6w ago

Price Chart

Loading chart...

Executive Summary

iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. Stockholders approved the 2026 Equity Incentive Plan (replacing the 2016 Plan), elected all nine director nominees, ratified KPMG as auditor, and approved an advisory vote on executive compensation. The filing is a routine governance update with no material financial impact.

Key Facts

  • 2026 Equity Incentive Plan approved by stockholders, replacing the 2016 Equity Incentive Plan
  • All nine director nominees elected with strong support (lowest 'for' vote was 20,263,076 for Bruce Bodaken)
  • KPMG LLP ratified as independent auditor for fiscal year 2026
  • Advisory vote on named executive officer compensation approved (26,185,232 for, 421,655 against)
  • Amended and restated certificate of incorporation to remove passthrough voting provision approved
  • Quorum achieved with 29,468,941 shares (89.69% of eligible shares) present at the meeting

Financial Impact

No material financial impact; routine governance and equity plan approval

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001388658-26-000049
Document: 0001388658-26-000049-index-headers.html0001388658-26-000049
Document: 0001388658-26-000049.txt0001388658-26-000049
18 reports for IRTC
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+60▲ +16.97%Feb 24, 2026
Filters
Rows
Reports for IRTC — sortable, filterable
TypeNow
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$125.35 $112.88▲ +9.95%▲ +8.05%$110.37 (+11.95%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$125.35 $112.88▼ −9.95%▼ −8.05%$110.37 (−11.95%)
Aug 4, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$127.13 $122.35▼ −3.76%▼ −2.52%$110.37 (−13.18%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$126.03 $117.17▼ −7.03%▼ −6.46%$110.37 (−12.43%)
Jun 15, 2026
15w ago
8-K
BEARISH ★ 6/10
$108.84 $112.55▼ −3.41%▼ −3.21%$110.37 (−1.41%)
Jun 5, 2026
17w ago
8-K
BULLISH ★ 5/10
$108.11 $126.03▲ +16.58%▲ +14.72%$110.37 (+2.10%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$115.61 $118.89▲ +2.84%▲ +5.98%$110.37 (−4.53%)
May 11, 2026
20w ago
144
NEUTRAL ★ 2/10
$118.31 $113.94▼ −3.69%▼ −1.97%$110.37 (−6.71%)
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$119.18 $109.17▼ −8.40%▼ −14.04%$110.37 (−7.39%)
Apr 30, 2026
22w ago
Press Release
BULLISH ★ 8/10
$120.80 $109.17▼ −9.63%▼ −14.91%$110.37 (−8.63%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access